| Date | Company Name | Details |
|---|---|---|
| 05-Nov-2026 | Fermenta Biotec. | Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve unaudited financial results for quarter and half year ended September 30 2026. |
| 05-Nov-2026 | M P Agro Inds. | MP Agro Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve the Unaudited Financial statements for the Quarter / Half year ended on 30th September 2026 and Limited Review Report thereto. |
| 05-Nov-2026 | Ultramarine Pig. | Ultramarine & Pigments Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financials Results (Standalone And Consolidated) Of The Company For The Quarter and Half year Ended 30Th September, 2026 |
| 05-Nov-2026 | Astrazeneca Phar | Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2026. We also confirm that the Trading Window remains closed for all Designated Persons from September 16 2026 to November 7 2026 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015. |
| 05-Nov-2026 | Cont. Chemicals | Continental Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve AS PER THE ATTACHED FILE |